Global biopharmaceutical company AstraZeneca today announced its participation at the Global Health Exhibition 2025, where it will highlight its expanding collaborations and local manufacturing supporting the Kingdom of Saudi Arabia’s Vision 2030 health agenda.
As a key partner of this year’s exhibition, AstraZeneca will bring together thought leadership, clinical expertise, and innovative healthcare solutions that accelerate access to advanced, patient-centred care across the Kingdom.
Advancing Innovation and Research Collaboration
AstraZeneca’s growing footprint in Saudi Arabia reflects its commitment to multi-sectoral partnerships that strengthen local R&D capabilities, support clinical trial infrastructure, advance rare disease diagnostics, and build workforce skills for the next generation of scientific leaders.
Leader's Summit Participation
During the Leaders’ Summit, Hatem Werdany, AstraZeneca’s Country President for Saudi Arabia, will join a high-level panel on Empowering a Biotechnology-Ready Health Workforce to discuss strategies for preparing healthcare professionals for an evolving innovation landscape.
In another key session, Professor Elias Mossialos, lead expert with the Partnership for Health System Sustainability and Resilience (PHSSR), will moderate a panel on strengthening 21st-century health systems to better prevent and manage non-communicable diseases such as kidney disease, cancer, and rare diseases.
Exhibition Experience
AstraZeneca will host an engaging exhibition space where visitors can explore its collaborative initiatives in research, clinical trials, and patient care innovation. Through engaging displays and expert discussions, attendees will gain insights into how AstraZeneca and its partners are shaping the future of healthcare in Saudi Arabia and beyond.
Hatem Werdany, Country President, Kingdom of Saudi Arabia, AstraZeneca:
"We are honoured to partner with the Global Health Exhibition 2025. This event represents an invaluable opportunity to engage with the global healthcare community at a regional level, share our latest innovations, and work collaboratively toward building more resilient, sustainable, and patient-focused health systems for the future."
For more information about AstraZeneca's participation in the Global Health Exhibition 2025, visit our booth at the exhibition.
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Media Partners
